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Abstract
Introduction Despite recent interest in measurement of central
venous oxygen saturation (ScvO2), there are no published data
describing the pattern of ScvO2 changes after major general
surgery or any relationship with outcome.
Methods ScvO2 and other biochemical, physiological and
demographic data were prospectively measured for 8 hours
after major surgery. Complications and deaths occurring within
28 days of enrolment were included in the data analysis.
Independent predictors of complications were identified with
the use of logistic regression analysis. Optimum cutoffs for
ScvO2 were identified by receiver operator characteristic
analysis.
Results Data from 118 patients was analysed; 123 morbidity
episodes occurred in 64 these patients. There were 12 deaths
(10.2%). The mean ± SD age was 66.8 ± 11.4 years. Twenty
patients (17%) underwent emergency surgery and 77 patients
(66%) were male. The mean ± SD P-POSSUM (Portsmouth
Physiologic and Operative Severity Score for the enUmeration
of Mortality and morbidity) score was 38.6 ± 7.7, with a
predicted mortality of 16.7 ± 17.6%. After multivariate analysis,
the lowest cardiac index value (odds ratio (OR) 0.58 (95%
confidence intervals 0.37 to 0.9); p = 0.018), lowest ScvO2
value (OR 0.94 (0.89 to 0.98); p = 0.007) and P-POSSUM
score (OR 1.09 (1.02 to 1.15); p = 0.008) were independently
associated with post-operative complications. The optimal
ScvO2 cutoff value for morbidity prediction was 64.4%. In the
first hour after surgery, significant reductions in ScvO2 were
observed, but there were no significant changes in CI or oxygen
delivery index during the same period.
Conclusion Significant fluctuations in ScvO2 occur in the
immediate post-operative period. These fluctuations are not
always associated with changes in oxygen delivery, suggesting
that oxygen consumption is also an important determinant of
ScvO2. Reductions in ScvO2 are independently associated with
post-operative complications.
Introduction
The successful use of central venous oxygen saturation
(ScvO2) as a haemodynamic goal in the management of early
sepsis has led to interest in the use of this parameter in surgi-
cal patients [1]. ScvO2 measurement requires placement of a
central venous catheter so that the tip lies in the superior vena
cava. Readings may be taken intermittently by blood sampling
and co-oximetry, or continuously with a spectrophotometric
catheter. Experimental studies have shown that changes in
ScvO2 closely reflect circulatory disturbances during periods
of hypoxia, haemorrhage and subsequent resuscitation [2,3].
Fluctuations correlate well with those of mixed venous satura-
tion (SvO2), although absolute values differ [2,3]. Observa-
tional studies have described changes in ScvO2 in various
groups [4]. In particular, the prognostic significance of ScvO2
reductions to below 65% has been demonstrated in traumaR694
APACHE = Acute Physiology and Chronic Health Evaluation; CI = cardiac index; DO2I = oxygen delivery index; GDT = goal-directed therapy; ICU = 
intensive care unit; OR = odds ratio; P-POSSUM = Portsmouth Physiologic and Operative Severity Score for the enUmeration of Mortality and mor-
bidity; ScvO2 = central venous saturation.
Critical Care    Vol 9 No 6    Pearse et al.
R695[5], severe sepsis [6], myocardial infarction [7] and cardiac
failure [8]. However, the only interventional trial of ScvO2 con-
ducted so far used a goal of 70% [1].
Although the association between cardiac index (CI), oxygen
delivery index (DO2I) and related parameters and outcome
after major surgery has been well described [9-14], only lim-
ited data are available describing ScvO2 values in the peri-
operative period [15]. The physiology of ScvO2 disturbances
is complex. The value of ScvO2 is determined by changes in
oxygen delivery and consumption, both of which are subject to
considerable variation during the peri-operative period [4]. It is
not appropriate to assume that either the normal value or fluc-
tuations in ScvO2 will be similar to those of other patient
groups. If ScvO2 is to be used in the haemodynamic assess-
ment of surgical patients, more detailed information is required
describing fluctuations during the peri-operative period. The
aim of this study was to describe changes in ScvO2 after major
general surgery and their relationship to outcome.
Methods
Patients
ScvO2 data were collected from adult patients enrolled in the
randomised study of post-operative goal-directed therapy
(GDT) [16]. All patients were deemed to be at high risk of
post-operative complications and were admitted to the inten-
sive care unit (ICU) immediately after major surgery. This study
was approved by the Local Research Ethics Committee of St
George's Healthcare National Health Service Trust.
Assessment
All patients had arterial and central venous catheters placed
before the commencement of surgery. The central venous
catheter was positioned with the tip within the superior vena
cava immediately above the right atrium. This position was ver-
ified by chest radiograph and adjusted if necessary. The fol-
lowing parameters were monitored continuously from arrival in
the ICU immediately after surgery and for the next 8 hours:
electrocardiograph, pulse oximetry, invasive arterial pressure,
central venous pressure and cardiac output. Arterial and cen-
tral venous blood gas analyses were performed by intermittent
blood sampling and co-oximetry (ABL 700; Radiometer,
Copenhagen, Denmark) at baseline and hourly during the 8
hours after surgery. This equipment was calibrated each hour,
and routine quality control checks were performed. Cardiac
output was measured by lithium indicator dilution and pulse
power analysis (LiDCO plus system; LiDCO Ltd., Cambridge,
UK). P-POSSUM (Portsmouth Physiologic and Operative
Severity Score for the enUmeration of Mortality and morbidity)
and APACHE II (Acute Physiology and Chronic Health Evalu-
ation II) scores were calculated at admission to the ICU
[17,18]. Complications and deaths occurring within 28 days
of enrolment were included in the data analysis. Complications
were prospectively defined, diagnosed by clinical staff and
verified by a member of the research team. This process
involved daily inspection of notes, radiological investigations,
laboratory data and clinical assessment.
Table 1
Demographic and biochemical data for patients with and without post-operative morbidity
Data class Complications (n = 64) No complications (n = 53) p
Demographic
Age (years) 67.0 ± 12.3 66.7 ± 10.4 0.89
Blood loss (ml) 1,200 (520–2,000) 1,000 (725–2,350) 0.88
GDT 27/64 (42%) 35/53 (66%) 0.02*
APACHE II score 9.9 ± 4.3 9.0 ± 3.8 0.28
P-POSSUM score 40.1 ± 8.1 36.8 ± 6.8 0.02*
ASA score 3 (2–3) 3 (2–3) 0.61
Biochemical
Baseline base excess (mmol l-1) -2.62 ± 3.03 -2.40 ± 3.31 0.71
Lowest base excess (mmol l-1) -3.67 ± 3.04 -4.30 ± 3.17 0.29
Base excess, 8-hour mean (mmol l-1) -2.73 ± 3.83 -2.31 ± 3.15 0.44
Baseline lactate (mmol l-1) 1.49 ± 0.81 1.38 ± 0.74 0.43
Highest lactate (mmol l-1) 1.93 ± 1.30 1.80 ± 0.88 0.55
Lactate, 8-hour mean (mmol l-1) 1.29 ± 0.81 1.23 ± 0.55 0.65
*Statistically significant difference. Data are presented as means ± SD, medians (interquartile range) or absolute values (%). APACHE, Acute 
Physiology and Chronic Health Evaluation; GDT, patients receiving goal-directed therapy; P-POSSUM, Portsmouth Physiologic and Operative 
Severity Score for the enUmeration of Mortality and morbidity
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Protocols for cardiovascular management during the immedi-
ate post-operative period are provided in detail elsewhere
[16]. Fluid challenges were guided by central venous pressure
in 56 patients and by stroke volume in 61 patients. The latter
group also received dopexamine if they did not achieve a DO2I
of 600 ml min-1 m-2 with fluid alone (GDT group). Once the 8-
hour study period was complete, all patients received stand-
ard care for the remainder of their ICU and hospital stay.
ScvO2 data were not used to guide clinical management at
any stage.
Statistical analysis
Data are presented as means ± SD where normally distrib-
uted, as medians (interquartile range) where not normally dis-
tributed or, for categorical variables, as a percentage of the
group from which they were derived. Normality was tested
with the Kolmogorov–Smirnov test. Categorical data were
tested with Fisher's exact test. Continuous data were tested
with the t test where normally distributed and the Mann–Whit-
ney U test where not normally distributed. Trends in physiolog-
ical parameters over time in the two groups were compared
with repeated-measures analysis of variance with Tukey's cor-
rection for multiple comparisons.
Univariate analysis was performed to test association with
complications and death. For data recorded hourly during the
study period, the baseline values, lowest values and the mean
over the 8-hour study period were tested. A multiple logistic
regression model was used to identify independent risk fac-
tors for post-operative complications. A stepwise approach
was used to enter new terms into the logistic regression
model, where p < 0.05 was set as the limit for inclusion of new
terms. Results of logistic regression are reported as adjusted
odds ratios (ORs) with 95% confidence intervals. Receiver
operator characteristic curves were constructed to identify
optimal cutoff values for association with outcome. The opti-
mum cutoff was defined as the value associated with the high-
est sum of sensitivity and specificity. Analysis was performed
with GraphPad Prism version 4.0 for Windows (GraphPad
Software, San Diego, CA, USA) and significance was set at p
< 0.05.
Table 2
Haemodynamic data for patients with and without post-operative morbidity
Data class Complications (n = 64) No complications (n = 53) p
Haemodynamic
Baseline heart rate (beats min-1) 82.1 ± 21.4 81.5 ± 15.5 0.87
Highest heart rate (beats min-1) 100.3 ± 19.9 106.6 ± 22.4 0.11
Heart rate, 8-hour mean (beats min-1) 86.0 ± 16.3 90.3 ± 16.0 0.15
Baseline MAP (mmHg) 93.9 ± 19.4 99.6 ± 20.2 0.12
Lowest MAP (mmHg) 74.5 ± 14.7 76.3 ± 12.8 0.48
MAP, 8 hour mean (mmHg) 90.8 ± 15.3 92.5 ± 12.9 0.52
Baseline CI (l min-1 m-2) 3.59 ± 1.39 3.87 ± 1.43 0.30
Lowest CI (l min-1 m-2) 2.74 ± 0.79 3.25 ± 1.32 0.02*
CI, 8-hour mean (l min-1 m-2) 3.93 ± 1.07 4.20 ± 1.55 0.30
Baseline DO2I (ml min-1 m-2) 494 ± 191 541 ± 229 0.26
Lowest DO2I (ml min-1 m-2) 364 ± 158 445 ± 218 0.02*
DO2I, 8-hour mean (ml min-1 m-2) 517 ± 206 581 ± 255 0.13
Baseline stroke volume (ml) 84 ± 30 88 ± 33 0.44
Lowest stroke volume (ml) 62 ± 25 70 ± 30 0.12
Stroke volume, 8-hour mean (ml) 70 ± 31 86 ± 32 0.29
ScvO2
Baseline (%) 76.2 ± 9.9 78.7 ± 6.2 0.11
Lowest (%) 63.4 ± 10.4 67.1 ± 7.7 0.03*
8-hour mean (%) 73.0 ± 6.6 75.0 ± 5.6 0.09
*Statistically significant difference. Data are presented as means ± SD. CI, cardiac index; DO2I, oxygen delivery index; MAP, mean arterial 
pressure; ScvO2, central venous saturation.
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Data was collected from 117 patients between November
2002 and August 2004. Five patients were excluded from the
analysis because ScvO2 data were collected with a spectro-
photometric catheter. Sixty-four patients developed 123 com-
plications in all. There were 12 deaths (10.2%). The mean ±
SD age was 66.8 ± 11.4 years. Twenty patients (17%) under-
went emergency surgery and 77 patients (66%) were male.
The APACHE II score was 9.5 ± 4.1, with a predicted mortality
of 10.3 ± 9.0%. The P-POSSUM score was 38.6 ± 7.7, with
a predicted mortality of 16.7 ± 17.6%. Fifty-seven (49%)
patients were extubated within 1 hour of surgery and a further
29 (25%) were extubated before the end of the 8-hour study
period.
Associations with outcome
Commonly measured physiological, biochemical and demo-
graphic variables are presented in Tables 1 and 2. Although
derangements in CI, DO2I and ScvO2 were frequently
observed, other parameters remained within the normal range
or were only slightly abnormal. Univariate analysis identified
five variables associated with post-operative complications.
These were the lowest ScvO2 value, the lowest DO2I value,
the lowest CI value, the P-POSSUM score and the use of
GDT. After multivariate analysis, the lowest CI value (OR 0.58
(95% confidence interval 0.37 to 0.9); p = 0.018), the lowest
ScvO2 value (OR 0.94 (0.89 to 0.98); p = 0.007) and P-POS-
SUM score (OR 1.09 (1.02 to 1.15); p = 0.008) were inde-
pendently associated with post-operative complications. The
lowest DO2I value and use of GDT were not independent pre-
dictors of outcome. The optimal value of ScvO2 to discriminate
between patients who did or did not develop complications
was 64.4% (sensitivity 67%, specificity 56%). Univariate anal-
ysis identified no associations with mortality.
Trends in ScvO2
Patients were divided into two groups by using the optimal
cutoff value for ScvO2. Those in whom the lowest ScvO2 value
was 64.4% or below were defined as the low ScvO2 group
and those in whom the lowest value was above 64.4% were
defined as the high ScvO2 group (see Table 3). Trends in
ScvO2 and DO2I are presented in Figures 1 and 2. During the
first post-operative hour there was a significant decrease in
ScvO2 in both the high ScvO2 group (79.8 ± 6.3% to 77.7 ±
5.8%; p = 0.016) and the low ScvO2 group (74.6 ± 9.7% to
66.6 ± 10.3%; p < 0.0001). DO2I and CI values did not
change significantly during this time.
Discussion
The major finding of this study is the occurrence of considera-
ble fluctuations in ScvO2 after major general surgery that have
prognostic significance. Multivariate analysis identified the
lowest ScvO2 value, lowest CI value and P-POSSUM score as
independent predictors of complications. This observation
supports the hypothesis that the association between reduc-
tions in ScvO2 and outcome is similar to that observed previ-
ously for CI and DO2I [9-13]. It is interesting to note that P-
POSSUM score was an independent predictor of complica-
tions, but APACHE II score was not. This may be because P-
POSSUM score was designed for use in surgical patients
using data from the UK, whereas APACHE II was designed for
use in mixed groups of critically ill patients using data from
North America [17,18]. As might be expected, the use of GDT
was associated with fewer post-operative complications.
However, this association was not independent of other
predictors of outcome. The observation of collinearity between
CI, DO2I and the use of GDT suggests that the level of DO2I
achieved by individual patients is more important than the
approach to haemodynamic management.
Table 3
Demographic and outcome data for high-ScvO2 and low-ScvO2 groups
Parameter High ScvO2 Low ScvO2 p
Number in group 64 53 -
Age 66 ± 12 69 ± 11 0.40
P-POSSUM 37.8 ± 7.4 39.0 ± 7.5 0.39
APACHE II score 9.8 ± 4.3 9.0 ± 3.9 0.30
Length of hospital stay (days) 12 (9–15) 14 (9–25) 0.25
Complications (number of patients) 29 (45%) 35 (66%) 0.03*
Complications (episodes per patient) 0.8 ± 1.1 1.4 ± 1.4 0.04*
Mortality 7 (11%) 4 (7%) 0.54
*Statistically significant difference. Data are presented as means ± SD, medians (interquartile range) or absolute values (%). APACHE, Acute 
Physiology and Chronic Health Evaluation; P-POSSUM, Portsmouth Physiologic and Operative Severity Score for the enUmeration of Mortality 
and morbidity; ScvO2, central venous saturation.
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tions was 64.4%. This is very similar to the value (65%) iden-
tified in other patient groups [5-7]. Large fluctuations in ScvO2
occur during the peri-operative period. Values of ScvO2
decreased significantly during the first hour after surgery, while
CI and DO2I remained unchanged. A significant increase in
oxygen consumption therefore occurred during this period
despite the fact that fewer than half of the patients were extu-
bated within 1 hour of surgery. This finding is consistent with
previous findings in cardiac surgical patients [14], as well as
earlier work by Shoemaker [13]. Post-operative oxygen con-
sumption is determined by various factors including pain,
emergence from anaesthesia, body temperature and shivering.
Peri-operative disturbances of ScvO2 cannot therefore be
assumed to relate solely to DO2I.
The 8-hour mean of ScvO2 was 75.0% in patients who did not
develop post-operative complications. This value was compa-
rable to previous measurements in healthy conscious patients
[19,20], but higher than those taken immediately before induc-
tion of anaesthesia [15] and in patients with good outcome
after trauma, severe sepsis, cardiac failure or myocardial inf-
arction [5-8]. It is notable that derangements in CI, DO2I and
ScvO2 were observed in the absence of similar disturbances
in other commonly measured biochemical and physiological
variables. This was despite the high rates of morbidity and
mortality in the study population. It is possible that distur-
bances in ScvO2, CI and DO2I might indicate the presence of
occult tissue hypoperfusion before disturbances in other
parameters.
The use of observational data from an interventional trial has
both advantages and disadvantages. In this study, goals for
arterial oxygen saturation, haemoglobin, heart rate, mean arte-
rial pressure, serum lactate and urine output were the same in
all patients. All clinical management and data collection were
closely supervised by a member of the research team in
accordance with a carefully defined treatment protocol. The
benefit of such rigorous study design must be offset against
the fact that, in some patients, intravenous fluid administration
was guided by central venous pressure, whereas in others
fluid management was guided by stroke volume and supple-
mented with low-dose dopexamine. It is an inherent problem
with studies of this type that the predictive nature of certain
variables may relate both to the initial cardiovascular distur-
bance and subsequent attempts to correct it. The large
number of statistical comparisons performed in the univariate
analyses may seem speculative. This is not the case; compar-
isons made were of variables in which an association with out-
come had previously been suggested [9-14,17,18,21]. We
were therefore obliged to identify all such associations in the
available data.
Conclusion
Reductions in ScvO2 are common after major surgery and are
associated with an increased rate of post-operative complica-
tions. Peri-operative changes in ScvO2 relate to both oxygen
consumption and delivery. Further evaluation of peri-operative
trends in ScvO2 should be performed before this variable is
used as a haemodynamic goal in surgical patients.
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Figure 1
Central venous saturation (ScvO2) in the 8 hours after major surgery. 
Results are means ± SD. *p < 0.0001 for low ScvO2 group; p = 0.02 
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is significant overall and for each individual time point (p < 0.0001).
Figure 2
Oxygen delivery index (DO2I) in the 8 hours after major surgeryI i  t   hours after major surgery. Results 
are means ± SD. The difference between the group with high central 
venous saturation (ScvO2) and the low ScvO2 group is significant over-
all (p = 0.005) but not for individual time points 7 and 8.
Key messages
• The successful use of central venous saturation in the 
management of severe sepsis has led to interest in the 
use of this variable in surgical patients.
• This analysis suggests that central venous saturation 
may have prognostic significance following major 
surgery.
• Further evaluation of peri-operative trends in central 
venous saturation is required.
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